1984
DOI: 10.1111/j.1600-065x.1984.tb00475.x
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Ig Class Secretion by Soluble Products of Certain T‐Cell Lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
43
0

Year Published

1985
1985
2009
2009

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(44 citation statements)
references
References 46 publications
1
43
0
Order By: Relevance
“…In 1989, when these two important papers were published, it was known that IL-4 directs LPS-activated B cells to switch to IgG1 and IgE (3)(4)(5). It was also known that, in the absence of added cytokine, B cells switch to IgG3 and IgG2b and that the addition of IFN-␥ induces IgG2a switching (6).…”
mentioning
confidence: 99%
“…In 1989, when these two important papers were published, it was known that IL-4 directs LPS-activated B cells to switch to IgG1 and IgE (3)(4)(5). It was also known that, in the absence of added cytokine, B cells switch to IgG3 and IgG2b and that the addition of IFN-␥ induces IgG2a switching (6).…”
mentioning
confidence: 99%
“…Normal splenic B cells from mice will switch to IgG3 and IgG2b, and much less frequently to other isotypes, after polyclonal stimulation in culture with bacterial lipopolysaccharide (LPS) (1). Recently it has become clear that lymphokines produced by T cells can regulate class switching in these cultures.…”
mentioning
confidence: 99%
“…Recently it has become clear that lymphokines produced by T cells can regulate class switching in these cultures. The addition of interleukin 4 (IL-4) to splenic B cells stimulated with LPS stimulates switching to IgG1 and IgE and markedly suppresses the switch to IgG3 and IgG2b (1)(2)(3). In contrast, LPS plus IL-5 promotes IgA, and LPS plus y-interferon promotes IgG2a responses (4)(5)(6).…”
mentioning
confidence: 99%
“…In about 25 % of all colorectal cancer patients p53-specific IgG antibodies were detected before the tumor was removed and their presence is an indicator of poor prognosis [18,19]. The appearance of demonstrable levels of anti-p53 IgG antibodies in the blood of patients indirectly points to the existence of p53-specific CD4 + Th cells, since isotype switching to IgG is Th cell dependent [20,21]. Indications for spontaneously acquired p53-specific Th immunity in humans have recently been obtained by Tilkin et al [22] who demonstrated p53-specific proliferative responses in three breast cancer patients.…”
Section: Introductionmentioning
confidence: 99%